Selenium-based antihypertensives. Rationale and potential

Drugs

Volumn 56, Issue 6, 1998, Pages 959-964

  May, Sheldon W ^a,b   Pollock, Stanley H ^a  

^a MERCER UNIVERSITY   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXY ALPHA METHYL PHENYL 2 AMINOETHYL SELENIDE; ANTIHYPERTENSIVE AGENT; ASCORBIC ACID; CATECHOLAMINE; DOPAMINE BETA MONOOXYGENASE; GLUTATHIONE PEROXIDASE; HYDROPEROXIDE; SELENIDE; SELENIUM DERIVATIVE; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIHYPERTENSIVE ACTIVITY; ARTHRITIS; ARTICLE; CANCER; CATECHOLAMINE METABOLISM; CELL DAMAGE; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG DESIGN; ENZYME ACTIVE SITE; HEART DISEASE; INSTRUMENTAL CONDITIONING; LOCOMOTION; MASS SPECTROMETRY; NONHUMAN; ORAL DRUG ADMINISTRATION; SELENIUM DEFICIENCY;

ANIMALS; ANTIHYPERTENSIVE AGENTS; ETHYLAMINES; HUMANS; ORGANOSELENIUM COMPOUNDS; SELENIUM;

EID: 0032433588     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199856060-00001     Document Type: Article

References (35)

1. Walter R, Schwartz IL, Roy J. Can selenoamino acids act as reversible biological antioxidants? Ann N Y Acad Sci 1972; 192: 175-80
2. 11b and selenium protect tissues against lipid peroxidation in rat tissue slices. J Nutr 1990; 120: 97-104
3. Caldwell KA,Tappel AL. Reactions of seleno- and sulfoamino acids with hydroperoxides. Biochemistry 1964; 3: 1643-7
4. Olcott HS, Brown WD, Van der Veen J. Selenomethionine as an antioxidant. Nature 1961; 191: 1201-2
5. Hamilton JW, Tappel AL. Lipid antioxidant activity in tissues and proteins of selenium-fed animals. J Nutr 1963; 79: 493-502
6. Fox JM. Selenium: nutritional implications and prospects for therapeutic medicine. Methods Find Exp Clin Pharmacol 1992; 14: 275-87
7. Parnham MJ, Grat E. Seleno-organic compounds and the therapy of hydroperoxide-linked pathological conditions. Biochem Pharmacol 1987; 36: 3095-102
8. Baum MK, Shor-Posner G, Lai S, et al. High risk of HIV-related mortality is associated with selenium deficiency. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 15: 370-4
9. Clark LC, Combs GF Jr, Turnbull BW, et al. Effect of selenium supplementation for cancer prevention in patients with carcinoma of the skin. JAMA 1996; 276: 1957-63
10. Subcommittee on the Tenth Edition of the RDA's Food and Nutrition Board. Commission on Life Sciences. National Research Council Recommended Dietary Allowances. 10th ed. Washington DC: National Academy Press, 1989
11. Stadtman TC, Selenocysteine. Annu Rev Biochem 1996; 65: 83-100
12. Ursini F, Bindoli A. The role of selenium peroxidases in the protection against oxidative damage of membranes. Chem Phys Lipids 1987; 44: 255-76
13. Voet D, Voet JG. Biochemistry. 2nd ed. New York: Wiley, 1995
14. Beck MA, Shi Q, Morris VC, et al. Rapid genomic evolution of a non-virulent Coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates. Nature Med 1995; 1: 433-6
15. Parnham MJ, Graf E. Pharmacology of synthetic organic selenium compounds. Prog Drug Res 1991; 36: 9-47
16. Shamberger RJ. Synthetic forms of selenium and their chemotherapeutic uses. In: Shamberger RJ, editor. Biochemistry of selenium, New York: Plenum, 1983: 273-310
17. Klayman DL. Selenium compounds as potential therapeutic agents. In: Klayman DL, Gunther WH, editors. Organic selenium compounds: their chemistry and biology. New York: Wiley, 1973: 727-61
18. Parnham MJ. The pharmaceutical potential of selenium. Pharm News 1996; 3: 7-10
19. Hoshida S, Aoki K, Nishida M, et al. Effects of preconditioning with ebselen on glutathione metabolism and stress protein expression. J Pharmacol Exp Ther 1987; 218: 1471-5
20. Herman HH, Husain PA, Colbert JE. et al. The enantiomeric specificity of the antihypertensive activity of 1-(phenylthio)-2-aminopropane, a synthetic substrate analogue for dopamine β-monooxygenase. J Med Chem 1991; 34: 1082-5
21. Kruse LI, Kaiser C, DeWolf WEJr, et al. Substituted 1-benzylimidazole-2-thiols as potent and orally active inhibitors of dopaimine b-hydroxylase. J Med Chem 1986: 29: 887-9
22. May SW, Herman HH, Roberts SF, et al. Ascorbate depletion as a consequence of product recycling during dopamine β-monooxygenase catalyzed selenoxidation. Biochem 1987; 26, 1626-32
23. May SW, Wimalasena K, Herman HH, et al. Novel antihypertensives targeted at dopamine β-monooxygenase: turnover-dependent cofactor depletion by phenyl aminoethyl selenide. J Med Chem 1988; 31: 1066-8
24. Wimalasena K, Herman HH, May SW. Effects of dopamine β-monooxygenase substrate analogs on ascorbate levels and norepinephrine synthesis in adrenal chromaffin granule ghosts. J Biol Chem 1989; 264: 124-30
25. Herman HH, Wimalasena K, Fowler LC, et al. Demonstration of the ascorbate dependenee of membrane-bound dopamine β-monooxygenase in adrenal chromaffin granule ghosts. J Biol Chem 1988; 263: 666-72
26. May SW, Young FK, Powers JL, et al. Mechanism-based inactivation of dopamine beta-monooxygenase in adrenal chromaffin cells. Biochem Biophys Res Commun 1996; 228: 278-84
27. Pollock SH, Herman HH, Fowler LC, et al. Demonstration of the antihypertensive activity of phenyl-2-aminoethyl selenide. J Pharm Exp Ther 1988; 246: 227-34
28. Rimmer SJ, Church MK. The pharmacology and mechanism of actions of histamine H1-antagonists. Clin Exp Allergy 1990; 20 Suppl. 2: 3-17
29. Brown JH. In: Gilman AG, Rall TW, Nies AS, et al. Goodman and Gilman's pharmacological basis of therapeutics. 8th ed. New York: McGraw-Hill, Inc. 1990: 159
30. Nadelmann J, Frishman WH. Clinical use of beta-adrenoceptor blockade in systemic hypertension. Drugs 1990; 39: 862-76
31. May SW, Wang L, Gill MM, et al. An orally active selenium based antihypertensive agent with restricted CNS permeability. J Pharm Exp Ther 1997; 283: 470-7
32. Selenium. In: Trace elements in human nutrition and health. Geneva: World Health Organisation. 1996: 105-22
33. Hu YJ, Chen Y, Zhang YQ, et al. The protective role of selenium on the toxicity of cisplatin-contained chemotherapy regimen in cancer patients. Biol Trace Elem Res 1997; 56: 331-41
34. Ihnat M, editor. Occurrence and distribution of selenium. Boca Raton (FL): CRC Press Inc., 1989
35. Zingaro RA, Cooper WC. editors. Selenium. New York: Van Nostrand Reinhold, 1974